Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Caliogna L et al. | 2022 | intact cell/cell culture, human adipose-derived mesenchymal stem cells and primary human osteoblasts | magnetic field, signals/pulses, 50/60 Hz, therapeutic/medical device | - |
Qiu L et al. | 2019 | intact cell/cell culture, human amniotic (FL) cells | 50/60 Hz, magnetic field | 0.4 mT |
Chen L et al. | 2021 | intact cell/cell culture, human amniotic (FL) cells | magnetic field, 50/60 Hz, also other exposures without EMF, co-exposure | 0.2–0.4 mT |
Ye AF et al. | 2022 | intact cell/cell culture, human amniotic epithelial cells (FL) | magnetic field, 50/60 Hz, low frequency | - |
Nafziger J et al. | 1997 | intact cell/cell culture, human bone marrow cells | magnetic field, 50/60 Hz | 10 µT–1 mT |
Phillips JL et al. | 1986 | intact cell/cell culture, human colon carcinoma cell line (Colo 205 and Colo 320 DM) | electric field, magnetic field, 50/60 Hz | 100 µT |
Samiei M et al. | 2020 | intact cell/cell culture, human dental pulp stem cells | magnetic field, 50/60 Hz | 0.5–1 mT |
Naghibzadeh M et al. | 2020 | intact cell/cell culture, human dermal fibroblasts | magnetic field, 50/60 Hz | 1–5 mT |
Vives L et al. | 2023 | intact cell/cell culture, human dermal fibroblasts | magnetic field, signals/pulses, 50/60 Hz, low frequency | - |
Watson JM et al. | 1998 | intact cell/cell culture, human endometrial stromal fibroblasts (primary cells and ESF-I (N5) cell line) and 12 endometrial, ovarian, and prostate cancer cell lines and immortazized human ovarian epithelial cells (OV-I) | magnetic field, 50/60 Hz, co-exposure | 200 µT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.